Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Regeneron Pharmaceuticals, Inc. REGN

Healthcare  —  Biotechnology
788.04 (7.98) (1.00%) as of 25 Sep
Market cap
$81.3B
P/E
18.8×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Regeneron Pharmaceuticals, Inc. (REGN) P/B ratio

As of 25 September 2026, Regeneron Pharmaceuticals, Inc. (REGN) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 1.8× (June 2025) to 19.3× (March 2015); the current reading is higher than 11% of that period. That is in line with the Biotechnology industry median of 2.5× and in line with the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 2.6× (1.35%)
FY2024 2.6× (29.57%)
FY2023 3.7× 9.20%
FY2022 3.4× (4.27%)
FY2021 3.6× (24.57%)
FY2020 4.7× 27.52%
FY2019 3.7× (19.66%)
FY2018 4.6× (30.48%)
FY2017 6.6× (25.92%)
FY2016 8.9× (41.63%)

Quarterly

Period P/B ratio Change
Jun 2026 2.0× (20.95%)
Mar 2026 2.6× (1.00%)
Dec 2025 2.6× 37.28%
Sep 2025 1.9× 2.09%
42 more quarters

Against its own ten years

Low 1.8× High 19.3×
Ten-year median 4.2×
Current reading's percentile 11

P/B ratio against peers

Company P/B ratio
REGN Regeneron Pharmaceuticals, Inc. 2.6×
RPRX Royalty Pharma PLC compare 2.6×
VRTX Vertex Pharmaceuticals Incorporated compare 6.6×
ARGX argenex SE compare 7.1×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 7.8×
MRNA Moderna, Inc. compare 11.7×
RVMD Revolution Medicines, Inc. compare 16.6×
ALNY Alnylam Pharmaceuticals, Inc. compare 25.3×
INSM Insmed, Inc. compare 33.8×
Biotechnology industry median 2.5×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on REGN